Peri-implantitis in patients with dental implants Oral Health
Conditions
Interventions
The study participants are recruited from the Department of Oral Implantology and Prosthodontics or the Department of Periodontology at the Academic Centre for Dentistry Amsterdam (ACTA). Using a bloc
Sponsors
Academic Center for Dentistry Amsterdam
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Systemically healthy, adult patients (=18 years old) 2. At least one failing dental implant (peri-implantitis) 3. The implant is in function for more than 1 year 4. Presents PIPD =5 mm, bleeding and/or suppuration on probing (BoP/SoP) 5. Marginal bone loss =3 mm detected radiographically
Exclusion criteria
Exclusion criteria: 1. Use of systemic antibiotics within the past 3 months 2. Any chronic medical disease or condition 3. Known allergy to penicillin or metronidazole 4. Use of anti-inflammatory prescription medications within the past 4 weeks 5. Pregnancy or lactation 6. Presence of implant mobility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peri-implant probing depth (PIPD) measured to the closest mm from the mucosal margin to the base of the pocket using a periodontal probe (PCP-UNC 15; Hu-Friedy, Chicago, IL, USA). Measured at baseline and at 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at baseline and 12 weeks: 1. Clinical attachment level (CAL) measured in mm using a stent with a fixed reference line with a periodontal probe (PCP-UNC 15; Hu-Friedy, Chicago, IL, USA) 2. Bleeding on probing (BoP), presence or absence, measured with a periodontal probe (PCP-UNC 15; Hu-Friedy, Chicago, IL, USA) 3. Suppuration on probing (SoP) presence or absence, measured with a periodontal probe (PCP-UNC 15; Hu-Friedy, Chicago, IL, USA) 4. Plaque Index (PI): the percentage of sites with plaque evaluated with visual inspection | — |
Countries
Netherlands
Outcome results
None listed